TABILIO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 3.031
EU - Europa 2.239
AS - Asia 1.942
SA - Sud America 313
Continente sconosciuto - Info sul continente non disponibili 129
AF - Africa 52
OC - Oceania 4
Totale 7.710
Nazione #
US - Stati Uniti d'America 2.969
SG - Singapore 883
UA - Ucraina 455
IE - Irlanda 342
SE - Svezia 333
CN - Cina 279
RU - Federazione Russa 262
BR - Brasile 239
VN - Vietnam 225
HK - Hong Kong 214
DE - Germania 202
IT - Italia 164
FI - Finlandia 151
GB - Regno Unito 115
FR - Francia 111
KR - Corea 101
TR - Turchia 45
IN - India 43
BD - Bangladesh 32
CA - Canada 29
AR - Argentina 27
JP - Giappone 18
IQ - Iraq 17
MX - Messico 17
UZ - Uzbekistan 17
AT - Austria 15
ZA - Sudafrica 15
CH - Svizzera 13
EC - Ecuador 11
BE - Belgio 10
CL - Cile 10
CO - Colombia 10
CZ - Repubblica Ceca 10
MA - Marocco 10
PK - Pakistan 10
PL - Polonia 10
NL - Olanda 9
GR - Grecia 8
AZ - Azerbaigian 7
ES - Italia 7
LB - Libano 7
PY - Paraguay 7
SA - Arabia Saudita 7
ID - Indonesia 6
RO - Romania 6
TN - Tunisia 6
VE - Venezuela 6
EG - Egitto 5
ET - Etiopia 5
OM - Oman 5
PH - Filippine 5
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
AU - Australia 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
MY - Malesia 3
TT - Trinidad e Tobago 3
AL - Albania 2
CR - Costa Rica 2
GT - Guatemala 2
JM - Giamaica 2
PS - Palestinian Territory 2
QA - Qatar 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
BG - Bulgaria 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
NP - Nepal 1
NR - Nauru 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 7.585
Città #
Singapore 626
Chandler 427
Dublin 342
San Jose 252
Jacksonville 248
San Mateo 243
Hong Kong 213
Ashburn 187
Boardman 132
Dong Ket 115
Seoul 101
Santa Clara 99
Beijing 83
Medford 79
Princeton 78
Ann Arbor 77
Moscow 72
Lauterbourg 66
Wilmington 63
Andover 59
Los Angeles 54
Helsinki 49
New York 46
Piscataway 43
Munich 40
Altamura 33
Shanghai 33
Ho Chi Minh City 32
Lawrence 32
Woodbridge 29
Perugia 25
Izmir 23
Houston 22
Hanoi 21
Saint Petersburg 21
Turku 21
Norwalk 18
The Dalles 17
Tokyo 17
Auburn Hills 16
Des Moines 16
São Paulo 15
Dallas 14
Orem 14
Falkenstein 13
Johannesburg 12
Brooklyn 11
Council Bluffs 11
Brussels 10
Foligno 10
Montreal 10
Phoenix 10
Redwood City 10
Rio de Janeiro 10
Chennai 9
Denver 9
London 9
Tashkent 9
Philadelphia 8
San Paolo di Civitate 8
Ankara 7
Baku 7
Brno 7
Charlotte 7
Chicago 7
Falls Church 7
Frankfurt am Main 7
Toronto 7
Baghdad 6
Dhaka 6
Haiphong 6
Lahore 6
Milan 6
New Delhi 6
Addis Ababa 5
Belo Horizonte 5
Bexley 5
Boston 5
Brasília 5
Buffalo 5
Curitiba 5
Da Nang 5
Dearborn 5
Mexico City 5
Quito 5
Rome 5
San Francisco 5
Warsaw 5
Amsterdam 4
Asunción 4
Barnet 4
Bologna 4
Memphis 4
Ottawa 4
Piediluco 4
Ribeirão Preto 4
Roubaix 4
Stockholm 4
Tunis 4
Atlanta 3
Totale 4.581
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 188
Sovraccarico di ferro in pazienti affetti da linfoma non Hodgkin (LNH) sottoposti a trapianto di midollo osseo autologo (A-TMO) ed emocromatosi ereditaria: esiste correlazione? Atti del IX Congresso Nazionale S.I.G.U. 184
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 173
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 168
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 155
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 146
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 142
Graft engineering for allogeneic haploidentical stem cell transplantation 137
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 136
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 134
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 130
Mesenchymal cells: a vehicle for gene therapy 127
Fourth international workshop on haploidentical transplants, Naples, Italy 127
Modulating the gene silencing: novel insights to overcame gene therapy major limitation also in orthopaedic applications. 124
Recruitment of beta-hexosaminidase activity on plasma membrane and human T-cell activation-52° Congresso SIB 122
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 122
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 122
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 120
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 119
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 118
Characterization of a Unique Cd133+ Leukemia Cell Line Responsive to FGF2 and TGFb1 114
Plasma membrane associated beta-hexosaminidase activity increases during human T-cells activation 114
Decreased bone mineral density after autologous stem cell transplantation. 109
Histone deacetylation in retroviral driven transgene silencing: role of TSA as a pharmacological support for gene therapy 107
Allogeneic transplantation across the HLA barriers. 107
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 106
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 106
Characterization of human lysosomal α-D-mannosidase in leukaemic and non leukaemic cells 106
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 106
Characterization of a unique CD133+leukemia cell line responsive to FGF2 and TGFbeta1 105
. Mismatched hematopoietic stem cell transplants in elderly patients. 105
Transplants across human leukocyte antigen barriers 104
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 103
Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation 101
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 101
Stem cell mobilization in normal donors. 98
Haploidentical stem cell transplantation for acute leukemia 94
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 94
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 94
Mismatched hematopoietic stem cell transplantation in secondary leukemia 93
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 93
A mature thymocyte-like phenotypic pattern on human cord circulating T-lymphoid cells. 93
High efficient gene transfer transduction using herpes simplex virus thymidine kinase (HSV-TK) gene: a comparison of different infection protocols. 91
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 89
Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFbeta1 88
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 86
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 85
Mesenchymal cells recruit and regulate T regulatory cells. 85
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. 85
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 84
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. 83
Full haplotype mismatched transplant in high risk acute leukemia patients. 82
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation. 81
IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment. 80
Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion based mechanism mediated by TNF-{alpha} 80
Diagnostic considerations on visceral leishmaniasis. Two case reports 80
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 79
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 79
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 78
Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. 78
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 77
HSV-TK gene as a potential tool for gene generating a controlled graft-versus-host/graft-versus-leukemia effect 76
Implicazione della deacetilazione degli istoni nel silenziamento di transgeni veicolati tramite vettori retrovirali: ipotetico ruolo del TSA come supporto della terapia genica. 75
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 74
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 74
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase. 72
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection. 68
Primary eyelid plasmacytoma. 67
Eradication of B-CLL by Autologous and Allogeneic Host Non-Reactive Anti-Third Party CTLs. 66
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 66
The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients. 64
Haematopoietic and Stromal Stem Cell Regulation by Extracellular Matrix Components and Growth Factors 59
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 59
Homing and survival of thymidine kinase transduced T-limphocytes into NOD/SCID mice. 57
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 55
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients. 54
Haploidentical stem cell transplantation in leukemia 54
Interleukin 7 retroviral gene transfer in human stromal cells enhances the survival of naive T lymphocyte. . 53
Totale 7.710
Categoria #
all - tutte 31.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022756 0 196 32 71 33 6 10 217 3 7 94 87
2022/20231.200 87 161 3 122 98 141 0 60 476 3 30 19
2023/2024443 27 47 30 4 1 9 101 24 56 13 46 85
2024/20251.079 24 118 26 56 183 25 21 78 193 71 184 100
2025/20262.313 172 163 124 304 299 235 410 111 240 192 36 27
2026/2027101 33 68 0 0 0 0 0 0 0 0 0 0
Totale 7.710